Log in to save to my catalogue

Cell-free, high-density lipoprotein-specific phospholipid efflux assay predicts incident cardiovascu...

Cell-free, high-density lipoprotein-specific phospholipid efflux assay predicts incident cardiovascu...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_39566e9a46204437a84f2a721f256ea3

Cell-free, high-density lipoprotein-specific phospholipid efflux assay predicts incident cardiovascular disease

About this item

Full title

Cell-free, high-density lipoprotein-specific phospholipid efflux assay predicts incident cardiovascular disease

Publisher

United States: American Society for Clinical Investigation

Journal title

The Journal of clinical investigation, 2023-09, Vol.133 (18), p.1-16

Language

English

Formats

Publication information

Publisher

United States: American Society for Clinical Investigation

More information

Scope and Contents

Contents

BACKGROUNDCellular cholesterol efflux capacity (CEC) is a better predictor of cardiovascular disease (CVD) events than HDL-cholesterol (HDL-C) but is not suitable as a routine clinical assay.METHODSWe developed an HDL-specific phospholipid efflux (HDL-SPE) assay to assess HDL functionality based on whole plasma HDL apolipoprotein-mediated solubiliz...

Alternative Titles

Full title

Cell-free, high-density lipoprotein-specific phospholipid efflux assay predicts incident cardiovascular disease

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_39566e9a46204437a84f2a721f256ea3

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_39566e9a46204437a84f2a721f256ea3

Other Identifiers

ISSN

1558-8238,0021-9738

E-ISSN

1558-8238

DOI

10.1172/JCI165370

How to access this item